Management of Gastric Cancer

Dear Colleagues,

(1) Gastric cancer remains an oncological burden with a low survival rate.

New epidemiological trends include an upward shift in the location of the primary tumour and a relative increase in advanced and diffuse-type tumours. These trends dictate the modification of surgical techniques towards a more individualized treatment approach.

Multidisciplinary management is essential to offer an adjusted treatment to the patient general condition and the tumor stage. New minimally invasive surgical treatments help to reduce surgical trauma and improve post-operative patient recovery. Oncological treatments have also evolved and definitive treatment by radio-chemotherapy can be proposed in specific cases.

We are pleased to invite you to contribute to this Special Issue, with high-quality original papers, as well as review articles, focusing on optimal patient selection and treatment strategies.

As an eminent scientist in the field, we would like to invite you to contribute to the Special Issue by submitting an article that falls within your area of expertise. Please feel free to nominate someone from your team, as co-author, if needed.

(2) Aim of the Special Issue and how the subject relates to the journal’s scope: Please make sure that your Special Issue is within the scope of the journal. You can check the scope in the journal menu: Aims and Scope. Additionally, the scope should not be too broad or too narrow. The aim is to have a collection of at least 10 articles, which we would assist with and work together with you to achieve, and the Special Issue can be printed in book form if this number is reached.

This Special Issue aims to present the most common advanced current options for the treatment of Gastric Cancer and the main open questions in the management of these patients, trying to depict an update of the available algorithms for everyday practice. Moreover, we summarize the design and preliminary results of the randomized trials in progress that will hopefully give definitive answers to the most debated issues in the field.

(3) Suggested themes and article types for submissions.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Molecular Biology;
• Neoajuvant therapy;
• Gastric Cancer Surgery;
• New Technologies;
• Adjuvant therapy.

We look forward to receiving your contributions.

Prof. Dr. Sergio Alfieri
Dr. Fausto Rosa
Dr. Valerio Papa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.